These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19059574)

  • 1. Pathophysiology of atrial fibrillation: insights into the renin-angiotensin system.
    Le Heuzey JY; Marijon E; Chachoua K; Waintraub X; Lepillier A; Otmani A; Lavergne T; Pornin M
    Arch Cardiovasc Dis; 2008; 101(11-12):787-91. PubMed ID: 19059574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the renin-angiotensin-aldosterone system in atrial fibrillation: from pathophysiology to clinical trials.
    Boos CJ; Lip GY
    J Hum Hypertens; 2005 Nov; 19(11):855-9. PubMed ID: 16094406
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure.
    Aksnes TA; Flaa A; Strand A; Kjeldsen SE
    J Hypertens; 2007 Jan; 25(1):15-23. PubMed ID: 17143167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension and atrial fibrillation: epidemiology, pathophysiology and therapeutic implications.
    Lau YF; Yiu KH; Siu CW; Tse HF
    J Hum Hypertens; 2012 Oct; 26(10):563-9. PubMed ID: 22129612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of renin-angiotensin system inhibitors in atrial fibrillation.
    Disertori M; Latini R; Maggioni AP
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):374; author reply 375. PubMed ID: 21451337
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapy with renin-angiotensin system blockers after pulmonary vein isolation in patients with atrial fibrillation: who is a responder?
    Berkowitsch A; Neumann T; Kuniss M; Janin S; Wojcik M; Zaltsberg S; Mitrovic V; Pitschner HF
    Pacing Clin Electrophysiol; 2010 Sep; 33(9):1101-11. PubMed ID: 20487340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renin-angiotensin system: a therapeutic target in atrial fibrillation.
    Patlolla V; Alsheikh-Ali AA; Al-Ahmad AM
    Pacing Clin Electrophysiol; 2006 Sep; 29(9):1006-12. PubMed ID: 16981926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atrial fibrillation--a complication in hypertension].
    Ukena CV; Neuberger HR; Böhm M
    MMW Fortschr Med; 2011 Oct; 153(41):47-8. PubMed ID: 22046841
    [No Abstract]   [Full Text] [Related]  

  • 9. Approach to management of atrial fibrillation in the Indian scenario.
    Vora A
    J Assoc Physicians India; 2007 Apr; 55 Suppl():30-2. PubMed ID: 18368864
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of lipid lowering therapy and renin angiotensin blockade in outcomes of patients with atrial fibrillation.
    Badheka AO; Tuliani T; Rathod A; Shenoy M; Afonso L; Jacob S
    Am J Cardiol; 2012 Apr; 109(8):1238. PubMed ID: 22464019
    [No Abstract]   [Full Text] [Related]  

  • 11. Atrial fibrillation and renin-angiotensin system.
    Serra JL; Bendersky M
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):215-23. PubMed ID: 19124423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation in essential hypertension: an issue of concern.
    Zhao LQ; Liu SW
    J Cardiovasc Med (Hagerstown); 2014 Feb; 15(2):100-6. PubMed ID: 24553088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New antiarrhythmic agents for atrial fibrillation and atrial flutter.
    Pecini R; Elming H; Pedersen OD; Torp-Pedersen C
    Expert Opin Emerg Drugs; 2005 May; 10(2):311-22. PubMed ID: 15934869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Are ACE inhibitors and angiotensin receptor blockers useful in the treatment of atrial fibrillation?].
    Raatikainen MJ; Huikuri HV
    Duodecim; 2003; 119(16):1505-7. PubMed ID: 14535023
    [No Abstract]   [Full Text] [Related]  

  • 15. Can losartan prevent new-onset atrial fibrillation in hypertensive patients more effectively than atenolol?
    Nattel S
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):332-3. PubMed ID: 16265553
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers on long-term outcome of catheter ablation for atrial fibrillation.
    Tayebjee MH; Creta A; Moder S; Hunter RJ; Earley MJ; Dhinoja MB; Schilling RJ
    Europace; 2010 Nov; 12(11):1537-42. PubMed ID: 20682557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A link between hypertension and atrial fibrillation: methods of treatment and prevention.
    Aksnes TA; Kjeldsen SE
    Curr Vasc Pharmacol; 2010 Nov; 8(6):769-74. PubMed ID: 20626338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation: Blockade of the renin-angiotensin system in atrial fibrillation.
    Kuzniatsova N; Shantsila E; Lip GY
    Nat Rev Cardiol; 2010 Aug; 7(8):428-30. PubMed ID: 20657612
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathophysiology of the renin-angiotensin-system in atrial fibrillation].
    Heusch G; Schulz R
    Dtsch Med Wochenschr; 2006 Apr; 131(15):817-20. PubMed ID: 16607602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atrial fibrillation: potential therapeutic interventions in the renin-angiotensin-aldosterone system].
    Dabrowski R; Szwed H
    Kardiol Pol; 2007 Apr; 65(4):440-5. PubMed ID: 17530565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.